Uams.edu arpediatrics.org Subcutaneous- ICD implants in a Pediatric center Srikant Das, MD Director, Electrophysiology and Pacing Arkansas Children’s Hospital.

Slides:



Advertisements
Similar presentations
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
Advertisements

Automated External Defibrillation
Thursday 4/12/2014 Hassan Alahmadi Medical Resident ( R1)
Pacemakers and Implantable Cardioverter-Defibrillators
Infusion Therapy.
Implantable Cardioverter Defibrillator Rebecca Boduch Biomedical Engineering University of Rhode Island.
Electrical Therapies Automated External Defibrillators Defibrillation
Defibrillator For Use in Minimally Invasive Surgery Kelly Moor Kathleen Kafka Stephen Browning.
Indications of ICD in 2010 Dr Mervat Aboulmaaty Professor of Cardiology Ain Shams University DAF 1 st EP course 2010.
Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Zac Chupka Jeff Signore.
Pacemaker Therapy and the Conducting System of the Heart By: Tom Kerrigan.
Pacemaker & its Classification
Pacemakers and Implanted Defibrillators Mike Harlan.
Pacemaker Follow-up Alpay Çeliker MD. Hacettepe University Department of Pediatric Cardiology 3rd International Summer School on Cardiac Arrhythmias, 9-12.
Cochlear Implants By Di’Aundria Davis.
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
Treatment of Heart Failure: Beyond Medical Therapy
Renal function and clinical outcomes of patients undergoing ICD and CRTD implantation- Data from the Israeli ICD Registry Alon Eisen, Mahmoud Souleiman,
Noninvasive evaluation of patients who are at risk for sudden cardiac death DR.A.YAMINISHARIF Tehran Heart Center.
May 2005 EP Show The EP Show COMPANION and CARE-HF Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis,
1 of 26 CRM AB Oct 2012 Physician Training THE S-ICD ® SYSTEM Patient Screening Prior to using these devices please review the user's manual for.
ELECTRODES FOR STIMULATION. Cardiac Pacemakers and Defibrillators  The heart is a natural example of a critical Bioelectromagnetic system.  An electrocardiogram.
By: Martin Grant Student no  Cardioversion is defined as a “synchronised direct current (DC) discharge, and … does not apply to ventricular.
Device and Antiarrhythmic Drugs: Advantages and Pitfalls Teresa Menendez Hood, M.D.
Infusion Therapy.
1 The Role of Medicare National Coverage in the Regulatory Process Steve Phurrough MD, MPA Director, Coverage and Analysis Group Centers for Medicare and.
Clinical Review AbioCor® Implantable Replacement Heart H Julie Swain M.D. Cardiovascular Surgeon Ileana Piña M.D. Heart Failure Cardiologist DRAFT.
IMPLANTABLE DEFIBRILLATOR By: Victor J. Gabbidon.
Trial Design Issues Associated with Evaluation of Distal Protection Devices in Diseased Saphenous Vein Grafts Bram D. Zuckerman, MD, FACC Medical Officer,
Patient work up – the arrhythmia nurse perspective Hilary Bugden RN, MSc Papworth Hospital Cambridge.
Advanced Therapies Lee R. Goldberg, MD, MPH Medical Director, Heart Failure and Cardiac Transplant Program University of Pennsylvania.
INTRODUCTION: INTRODUCTION: implantable cardioverter-defibrillators (ICDs) have clearly demonstrated to terminate an elevated percentage of sustained ventricular.
Dr Eric Prystowsky Director Clinical Electrophysiology Laboratory St Vincent Hospital, Indianapolis Dr Leslie Saxon Chief, Electrophysiology Laboratory.
EP show – June 2004 EP show The EP show: Risk stratification for sudden death Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent.
Arrhythmias.
Using an Automatic External Defibrillator (AED) Korean Red Cross Important Definitions  Ventricular Fibrillation (VF): The most common abnormal rhythm.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Cardiovascular Therapeutic Management 2013
22nd April 2009 ECG Recording and Basic Interpretation.
CRT Overview This lecture is intended to give a basic overview of HF to include: -General knowledge of the cardiac cycle and how a normal heart should.
METHODS The EASYTRAK 2 lead was studied along with the CONTAK  RENEWAL  2/4/4HE device in the Device Evaluation of the CONTAK RENEWAL 2/4/4HE with EASYTRAK.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and Efficacy of the Totally Subcutaneous Implantable.
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator  Mohammad-Ali.
Annual Outcomes With Transcatheter Valve Therapy
Annual Outcomes With Transcatheter Valve Therapy
Cardiovacular Research Technologies
Pacemakers and Devices – Interactive Session
Tom F. Brouwer et al. JACEP 2016;2:
CARDIAC DEFIBRILLATORS
Physician Training THE S-ICD® SYSTEM
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant  Masaki Tsukashita, MD, PhD, Yoshifumi Naka,
CARDIAC DEFIBRILLATORS
Tom F. Brouwer et al. JACEP 2016;2:
The EP Show: CMS reimbursement decision for ICDs
Challenges in the diagnosis and management of idiopathic ventricular fibrillation  Jonathan Lipton, MD, PhD, George J. Klein, MD, Raymond W. Sy, MBBS,
T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome 
Surgical and electrophysiological considerations in the management of a patient with a subcutaneous implantable cardioverter-defibrillator undergoing.
Inside-out abrasion and contained conductor cable externalization in a defibrillation lead with asymmetric conductor cable lumen distribution  Ernest.
Pierre Imbert, M. D. , Philippe D'Ingrado, M. D. , Maxime Cavalier, M
Arthroscopic Superior Capsular Reconstruction With Acellular Dermal Allograft Using Push-In Anchors for Glenoid Fixation  William T. Pennington, M.D.,
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator  Mohammad-Ali.
Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with dextrocardia, tetralogy of Fallot, and conduction disease 
Inappropriate shocks in a patient with a subcutaneous implantable cardioverter- defibrillator  Sana M. Al-Khatib, MD, MHS, FHRS, Sasmrita Belbase, NP,
Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular.
Nothing inside the heart – Combining epicardial pacing with the S-ICD
Unusual fracture in a Durata lead with shock coil fragmentation and cable externalization  Toshiaki Sato, MD, Kyoko Soejima, MD, Hideaki Yoshino, MD,
Automated External Defibrillation
Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks  Omid Kiamanesh, MD, Jacob M. Larsen, MD, PhD,
Orthostatic increase in defibrillation threshold leading to defibrillation failure and prolonged cardiac arrest in a sitting position: Lessons from a.
Presentation transcript:

uams.edu arpediatrics.org Subcutaneous- ICD implants in a Pediatric center Srikant Das, MD Director, Electrophysiology and Pacing Arkansas Children’s Hospital

uams.edu arpediatrics.org Background An entirely subcutaneous ICD system (S-ICD) avoids the need for the placement of electrodes within the heart and can provide clinical advantages especially in pediatric population. Approved by the Food & Drug Administration (FDA) in 2012 Gained Category 1 CPT Codes in January 2015 Shown to be highly effective. We describe the initial experience of S-ICD implants in four children in electrophysiology laboratory in Arkansas Children’s Hospital.

uams.edu arpediatrics.org S-ICD TM System  Sensing Configuration  System Components 145g (78.2 X 65.5 X 15.7 mm) Emblem 130g (69.1 X 83.1 X 12.7 mm)

uams.edu arpediatrics.org S-ICD in children

uams.edu arpediatrics.org Historical ICD Challenges The ICD lead is considered the most fragile component of a transvenous ICD system. Source: Kleeman 2007

uams.edu arpediatrics.org Historical ICD Challenges The incidence of transvenous lead failure increases over time. Source: Kleeman 2007

uams.edu arpediatrics.org A New Alternative: S-ICD TM System The S-ICD TM System provides defibrillation therapy via a completely subcutaneous defibrillation system.

uams.edu arpediatrics.org Clinical Benefits Because the heart and vasculature remain untouched, the S- ICD TM System reduces the risks associated with TV-ICDs

uams.edu arpediatrics.org Design of S-ICD The S-ICD System is comprised of the following four devices: 1. Pulse Generator – 80-J biphasic shock – Charge time to 80-J ≤ 10 seconds – 5.1 year longevity – 30 seconds post-shock pacing 2.Q-TRAK Subcutaneous Electrode 3.Q-GUIDE Electrode Insertion Tool (EIT) 4.Q-TECH Programmer

uams.edu arpediatrics.org System Components In addition to the pulse generator and subcutaneous electrode, the S-ICD TM System includes an electrode insertion tool and programmer.

uams.edu arpediatrics.org START Study The START study showed that the S-ICD TM System is equivalent to a TV-ICD in sensitivity and superior to a TV-ICD in specificity Source: Gold 2011

uams.edu arpediatrics.org Registry Results The complication free rate was 94% at 180 days Source: Lambiase 2014

uams.edu arpediatrics.org Danish TV-ICD Registry Results Complication rates: Danish TV-ICD and EFFORTLESS S-ICD registry results

uams.edu arpediatrics.org Patient Screening  ECG Screening Tool  ECG Screening Configuration  QRS Evaluation  Lead Acceptability

uams.edu arpediatrics.org Optimal Sensing Configuration The optimal S-ICD TM System sensing configuration is a parasternal electrode and left lateral pulse generator. Source: Bardy

uams.edu arpediatrics.org ECG Screening Tool Pre-implant screening ensures the patient is a good candidate for S-ICD TM System implant and subcutaneous defibrillation therapy.

uams.edu arpediatrics.org ECG Screening Configuration Adjust the gain as needed to ensure the peak of each R wave is completely visible…. not clipped as shown here. CRM AC FEB 2015

uams.edu arpediatrics.org ECG Screening Configuration Use a three-lead configuration that represents the intended location of the implanted pulse generator and subcutaneous electrodes.

uams.edu arpediatrics.org Sensing Configuration The pulse generator is implanted at the mid-axillary line. The proximal sensing ring is placed near the xiphoid, and the distal sensing ring in the superior sternum.

uams.edu arpediatrics.org Sensing Vectors The S-ICD TM System uses three sensing vectors to interpret subcutaneous ECG signals.

uams.edu arpediatrics.org QRS Evaluation Select the color profile that best matches the QRS complexes on the ECG strip. Align left edge of color profile to QRS onset.

uams.edu arpediatrics.org QRS Evaluation Ensure the entire QRS complex and T wave fit within the color profile.

uams.edu arpediatrics.org Lead Acceptability A patient is considered suitable for an S-ICD ® System implant if at least one ECG lead is acceptable for each tested posture.

uams.edu arpediatrics.org S-ICD TM System Implant  X-ray Landmarks  Patient Preparation  Initial Incisions  Electrode Placement  Pulse Generator Placement  X-ray Assessment

uams.edu arpediatrics.org X-Ray Landmarks In the AP view, the sensing rings are parallel and about 1 cm from the sternal midline. The pulse generator is at the mid-axillary line.

uams.edu arpediatrics.org X-Ray Landmarks In the left lateral view, the sensing rings appear to lie on the sternal surface. The pulse generator is at the mid-axillary line, in a position that is neither too anterior or too posterior.

uams.edu arpediatrics.org Implantation Procedure

uams.edu arpediatrics.org Patient Preparation Refer to landmarks to mark incision sites and the sternal midline.

uams.edu arpediatrics.org Patient Preparation Drape to expose the incision sites and sternal midline.

uams.edu arpediatrics.org Initial Incisions Ensure the pulse generator pocket is below adipose tissue and deep enough to accommodate the pulse generator.

uams.edu arpediatrics.org Initial Incisions Make a 2 to 3 cm horizontal incision just left and 1 cm above of the xiphoid midline. Place two sutures, spaced to match the grooves of the suture sleeve.

uams.edu arpediatrics.org Proximal Electrode Placement Tie distal electrode tip to EIT. Place suture sleeve on electrode body, 1 cm from proximal sensing ring.

uams.edu arpediatrics.org Distal Electrode Placement Use distal electrode to identify and mark superior incision site. Tunnel along sternum from xiphoid to superior incision. Pull suture with attached distal electrode through tunnel.

uams.edu arpediatrics.org Pulse Generator Placement Use suture to anchor pulse generator in pocket and secure the electrode at the xiphoid and superior incisions. Keep sutures loose enough to allow for range of motion.

uams.edu arpediatrics.org Pulse Generator Placement Confirm the electrode connector pin is inserted halfway into pin receptacle. Gently tug electrode to confirm the connection is secure.

uams.edu arpediatrics.org Post implant in patient # 4

uams.edu arpediatrics.org Age (y)DiagnosisScreenDFTDeviceProcedureFollow up 1.15,FIdiopathic ventricular fibrillation; s/p cardiac arrest Leads I,II,III 65 JS-ICD 145g (78.2 X 65.5 X 15.7 mm) 3 incisions 92 min 9 mo 2.17,MHeart transplant with ischemic cardiomyopathy and LVEF < 30% Leads I,II,III 65 JS-ICD 145g (78.2 X 65.5 X 15.7 mm) 3 incisions 112 min 9 mo 3.16,FHypertrophic cardiomyophy s/p transvenos ICD; inappropriate shocks and lead failure Leads II,III 65 JS-ICD Emblem 130g (69.1 X 83.1 X 12.7 mm) 2 incisions 120 min 3 mo 4.16,Fs/p sudden cardiac arrest; idiopathic ventricular fibrillation Leads I,II,III 65 JS-ICD Emblem 130g (69.1 X 83.1 X 12.7 mm) 2 incisions 80 min 3 mo

uams.edu arpediatrics.org Induction Testing  Induction Setup  Induction Progress  Time to Therapy Evaluation

uams.edu arpediatrics.org Time to Therapy Evaluation Evaluate the time to therapy using an external ECG strip.

uams.edu arpediatrics.org Appropriate vs Inappropriate Shocks Dual-zone programming enhances AF/SVT vs VT/VF discrimination to determine the appropriateness of shock therapy. Source: Weiss 2013

uams.edu arpediatrics.org Rhythm Discrimination The S-ICD TM System analyzes static morphology, dynamic morphology, and QRS width to classify the subcutaneous ECG signal in the Conditional zone.

uams.edu arpediatrics.org Algorithm Architecture Summary

uams.edu arpediatrics.org Advantages Advantages: Eliminates potential for infection and damage to venous system May be implanted using anatomical landmarks without fluoroscopy Potential for less inappropriate shocks in children

uams.edu arpediatrics.org Disadvantages: Size – Twice that of current T-ICD Battery life – 5 to 6 years as opposed to >8-10 with TV-ICD Does not provide anti-tachycardia pacing (ATP) or bradycardia pacing

uams.edu arpediatrics.org X-ray Assessment Optimal device placement

uams.edu arpediatrics.org Reimbursement Currently, the S-ICD System is covered nationally by Medicare, Aetna, Cigna and others, and regionally by numerous private and Medicaid plans.

uams.edu arpediatrics.org Conclusion The S-ICD system represents a viable alternative to conventional TV-ICD therapy in patients at risk of death from VT/VF Low rate of major complications thus far in clinical studies Young patients could benefit the most from this system. The implantation can be safely performed in catheterization laboratory in children.